S.C. IOR Past Earnings Performance

Past criteria checks 3/6

S.C. IOR has been growing earnings at an average annual rate of 53.2%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 6.1% per year. S.C. IOR's return on equity is 2.1%, and it has net margins of 18.6%.

Key information

53.2%

Earnings growth rate

69.0%

EPS growth rate

Medical Equipment Industry Growth14.9%
Revenue growth rate6.1%
Return on equity2.1%
Net Margin18.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How S.C. IOR makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVB:IORB Revenue, expenses and earnings (RON Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24183200
30 Jun 24184200
31 Mar 24182200
31 Dec 23171190
30 Sep 2323-2190
30 Jun 2323-1180
31 Mar 23220170
01 Jan 23231160
30 Sep 22152150
30 Jun 22162140
31 Mar 22161150
01 Jan 22170150
30 Sep 2117-1150
30 Jun 2117-3150
31 Mar 2116-4150
01 Jan 2115-3150
30 Sep 2014-6140
30 Jun 2014-6140
31 Mar 2014-4140
01 Jan 2016-3140
30 Sep 19181140
30 Jun 19190140
31 Mar 19200140
01 Jan 19200140
30 Sep 1819-2140
30 Jun 18170140
31 Mar 1817-1140
01 Jan 1817-1130
01 Oct 1717-1130
30 Jun 1718-1130
31 Mar 1717-1140
01 Jan 1717-1140
01 Oct 1617-3140
30 Jun 1618-4150
31 Mar 1617-3150
31 Dec 1517-2140
30 Sep 15160140
30 Jun 15151130
31 Mar 15140130
01 Jan 15130130

Quality Earnings: IORB has high quality earnings.

Growing Profit Margin: IORB became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IORB has become profitable over the past 5 years, growing earnings by 53.2% per year.

Accelerating Growth: IORB has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: IORB has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.4%).


Return on Equity

High ROE: IORB's Return on Equity (2.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 07:23
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

S.C. IOR S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution